Address And Details

PO Box 55932 , Boston, MA 02205-5932
Fund Manager Daniel J. Grana
Manager Tenure 2 Years

Strategy And Objective

Janus Henderson Emerging Markets Fund seeks long-term growth of capital. The Fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in equity securities of companies in emerging market countries. Equity securities include common stocks and related securities, such as preferred stock, convertible securities and depositary receipts. Emerging market countries are all countries represented by the MSCI Emerging Markets Indexsm and/or those countries considered to be developing by the World Bank, the International Finance Corporation or the United Nations. These countries typically are located in the Asia-Pacific region, Eastern Europe, Central and South America, and Africa. Companies in emerging market countries are broadly defined to include any company that meets one or more of the following tests: (i) its country of organization, its primary business office, and/or the principal trading market of its stock are located in an emerging market country; (ii) 50% or more of its assets are located in emerging market countries, (iii) 50% or more of its revenues are derived from emerging market countries; or (iv) a company with similar emerging markets exposure. In addition to the Fund s main investments, the Fund may invest no more than 20% of its net assets in the securities of issuers in developed market countries. The Fund may invest in derivatives, which are instruments that have a value derived from, or directly linked to, an underlying asset, such as equity securities, fixed-income securities, commodities, currencies, interest rates, or market indices. In particular, the Fund may invest in derivatives such as futures, options, forward currency contracts, warrants, and swaps for various investment purposes, such as to gain exposure to a particular portion of the market, manage or hedge portfolio risk, or enhance return. The portfolio manager employs both a top-down and bottom-up approach to select investments for the Fund. The top-down approach involves a macro analysis of factors that include an issuer s economic growth profile, the stages of a country s development, and trends in a country s governance and regulatory framework. The bottom-up analysis focuses on fundamental research and considers, among other factors, a company s valuation, growth potential, competitive positioning, projected future earnings, cash flows, governance, and dividends. The Fund has the ability to invest more heavily in either growth or value securities depending on market conditions and the portfolio manager s convictions. The Fund may engage in active and frequent trading to achieve its investment objective. The Fund generally sells a stock when, in the portfolio manager s opinion, there is a deterioration in a company s fundamentals or a company s revenue growth has slowed. The Fund may also sell stock if the portfolio manager believes that a company has achieved its target price or a superior investment opportunity arises. The Fund may engage in active and frequent trading to achieve its investment objective. At times, the Fund may invest to a significant degree in issuers located in a single country or region, which particularly includes China. In addition, the Fund may invest in securities issued by small- and mid-sized companies and in less seasoned issuers.

Net Asset Value

as of 5:46 PM ET 09/17/2021


  • 1 Week
  • -2.33%
  • 1 Month
  • +1.67%
  • 3 Months
  • -5.23%
  • 1 Yr Return
  • +19.82%
  • 5 Yr Return
  • +35.91%

Equity Sector Breakdown

Technology 25.20%
RetailTrade 15.65%
Finance 12.94%
IndustrialCyclical 12.26%
NonDurables 5.72%
Services 4.90%
Health 3.23%
Energy 2.57%
ConsumerDurables 1.81%
Utilities 1.03%

Asset Allocation

Asset Type % Of Allocation
Stocks 96.76%
ForeignStocks 87.44%
Preferred 0.49%
Cash 0.00%
Bonds 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 20.83 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -1.75 -3.24 -7.96
Beta 0.80 0.74 0.90
R Squared 0.55 0.43 0.47
Std Deviation 19.95 17.09 17.73
Sharpe Ratio 0.64 0.56 n/a

Purchase Information

as of 5:45 PM ET 09/16/2021
Minimum Initial $1000000
Minimum Additional $0
Minimum Initial IRA $0


Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +24.56%
  • +46.34%
+24.56% +46.34%
3 Year
  • +11.73%
  • +12.66%
+11.73% +12.66%
10 Year
  • +4.87%
  • +4.68%
+4.87% +4.68%
Life Of Fund
  • +3.49%
  • +4.02%
+3.49% +4.02%

Top 10 Holdings

Symbol Company Name % Of Assets
035420.K NAVER CORP 2.40%

Recent Articles from TheStreet

Chinese Investors Mock Asset Managers And Offer Advice On Stock Picks For Cautious Approach To Renewables Sector

Stocks May Drop 20% as Stimulus Eases, Growth Slows: Morgan Stanley

Stocks could drop 20% as fiscal stimulus is withdrawn and economic growth slows, a Morgan Stanley strategist says.

AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment

AstraZeneca Stock Rises on Progress With Breast-Cancer Treatment

AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.

Cryptocurrency Lead

Cryptocurrency Price Check: Bitcoin Tumbles on Evergrande Woes

Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.

China Aims To Strengthen Its Semiconductor Supply Chain With New Standards Group That Includes Huawei, SMIC

Brooks Automation Stock Jumps on Plan to Sell Chip Solutions Unit for $3B

Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.

DR Horton, Verizon, HCA Holdings Top Analysts' Actions Monday

DR Horton Trims 2021 Sales Forecast Amid Supply Chain Disruptions

DR Horton said "significant disruptions in the supply chain ... along with tightness in the labor market" will lead to a modestly lower full-year sales forecast.

11. Colgate-Palmolive

Colgate-Palmolive Underappreciated, Deutsche Bank Says, Lifting to Buy

Colgate-Palmolive stock was upgraded to buy with an $86 price target at Deutsche Bank.

Watch Jim Cramer Live 9/20

Video: Jim Cramer on the Market Selloff, Evergrande, Debt Ceiling, Fed, Pfizer

Jim Cramer discusses the market selloff, Evergrande, debt ceiling talks, the upcoming Federal Reserve meeting, Pfizer and more in his latest video interview with TheStreet.

Wynn Lead

Wynn Resorts 'Worth Risk' of Macau Restrictions, Morgan Stanley Says

Wynn Resorts faces regulatory uncertainty in Macau, but Morgan Stanley says the casino operator is still 'worth the risk.'

Chinese Tesla Challenger Xpeng Prices Its P5 Sedan From US$24,700 After Subsidies As Battle For EV Buyers Intensifies

Tesla Wider Self-Driving Effort Reportedly Opposed by NTSB Chief

Tesla wants to expand its autonomous-driving effort to help cars make their way through cities, not just highways.

BioNTech and Pfizer's mRNA-based vaccine candidate BNT162b2 has proven to be more than 90 per cent effective in preventing Covid-19 infections. Photo: Reuters

Premarket Movers Monday - Pfizer, Netflix, Li Auto, AstraZeneca

Stocks moving in premarket trading Monday include Pfizer, Netflix, Li Auto, AstraZeneca and Bank of America.